APERAM S.A. NY SHS/1 O.N.APERAM S.A. NY SHS/1 O.N.APERAM S.A. NY SHS/1 O.N.

APERAM S.A. NY SHS/1 O.N.

No trades
See on Supercharts

Price target

30.810.000.00%
The 9 analysts offering 1 year price forecasts for 7AAN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to 7AAN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


7AAN EPS for the last quarter is 0.85 EUR despite the estimation of 0.19 EUR. In the next quarter EPS is expected to reach 0.28 EUR. Track more of APERAM S.A. NY SHS/1 O.N. financials and stay on top of what is up with the company.
In the next quarter APERAM S.A. NY SHS/1 O.N. revenue is expected to reach ‪1.57 B‬ EUR. Check out APERAM S.A. NY SHS/1 O.N. revenue and earnings and make informed decisions.
According to analysts, 7AAN price target is 30.81 EUR with a max estimate of 42.32 EUR and a min estimate of 21.51 EUR. Check if this forecast comes true in a year, meanwhile watch APERAM S.A. NY SHS/1 O.N. stock price chart and keep track of the current situation with 7AAN news and stock market news.
We've gathered opinions of 8 analysts rating 7AAN stock in the past 3 months. After counting all points of view, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.